Global Diabetes Drug Delivery Pump Market Growth 2025-2031
Description
The global Diabetes Drug Delivery Pump market size is predicted to grow from US$ 4627 million in 2025 to US$ 9052 million in 2031; it is expected to grow at a CAGR of 11.8% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A Diabetes Drug Delivery Pump, commonly known as an insulin pump, is a medical device used to deliver insulin continuously or in programmed doses to help people with diabetes manage their blood glucose levels. The pump mimics the function of a healthy pancreas by providing basal (background) and bolus (mealtime) insulin, offering an alternative to multiple daily injections. It improves glycemic control, reduces hypoglycemia risk, and enhances treatment flexibility and patient quality of life.
United States market for Diabetes Drug Delivery Pump is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Diabetes Drug Delivery Pump is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Diabetes Drug Delivery Pump is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Diabetes Drug Delivery Pump players cover Medtronic, Insulet, Tandem, SOOIL, Microtech Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Diabetes Drug Delivery Pump Industry Forecast” looks at past sales and reviews total world Diabetes Drug Delivery Pump sales in 2024, providing a comprehensive analysis by region and market sector of projected Diabetes Drug Delivery Pump sales for 2025 through 2031. With Diabetes Drug Delivery Pump sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diabetes Drug Delivery Pump industry.
This Insight Report provides a comprehensive analysis of the global Diabetes Drug Delivery Pump landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diabetes Drug Delivery Pump portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diabetes Drug Delivery Pump market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diabetes Drug Delivery Pump and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diabetes Drug Delivery Pump.
This report presents a comprehensive overview, market shares, and growth opportunities of Diabetes Drug Delivery Pump market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Tube Insulin Pumps
Tubeless Insulin Pumps (Patch Pumps)
Segmentation by Application:
Hospitals
Homecare
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Medtronic
Insulet
Tandem
SOOIL
Microtech Medical
Zhuhai Fornia
Phray
Apex Medical
Ypsomed
MedNovo
EOFlow
CeQur Simplicity
Medtrum
PharmaSens
ViCentra
Key Questions Addressed in this Report
What is the 10-year outlook for the global Diabetes Drug Delivery Pump market?
What factors are driving Diabetes Drug Delivery Pump market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Diabetes Drug Delivery Pump market opportunities vary by end market size?
How does Diabetes Drug Delivery Pump break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A Diabetes Drug Delivery Pump, commonly known as an insulin pump, is a medical device used to deliver insulin continuously or in programmed doses to help people with diabetes manage their blood glucose levels. The pump mimics the function of a healthy pancreas by providing basal (background) and bolus (mealtime) insulin, offering an alternative to multiple daily injections. It improves glycemic control, reduces hypoglycemia risk, and enhances treatment flexibility and patient quality of life.
United States market for Diabetes Drug Delivery Pump is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Diabetes Drug Delivery Pump is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Diabetes Drug Delivery Pump is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Diabetes Drug Delivery Pump players cover Medtronic, Insulet, Tandem, SOOIL, Microtech Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Diabetes Drug Delivery Pump Industry Forecast” looks at past sales and reviews total world Diabetes Drug Delivery Pump sales in 2024, providing a comprehensive analysis by region and market sector of projected Diabetes Drug Delivery Pump sales for 2025 through 2031. With Diabetes Drug Delivery Pump sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diabetes Drug Delivery Pump industry.
This Insight Report provides a comprehensive analysis of the global Diabetes Drug Delivery Pump landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diabetes Drug Delivery Pump portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diabetes Drug Delivery Pump market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diabetes Drug Delivery Pump and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diabetes Drug Delivery Pump.
This report presents a comprehensive overview, market shares, and growth opportunities of Diabetes Drug Delivery Pump market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Tube Insulin Pumps
Tubeless Insulin Pumps (Patch Pumps)
Segmentation by Application:
Hospitals
Homecare
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Medtronic
Insulet
Tandem
SOOIL
Microtech Medical
Zhuhai Fornia
Phray
Apex Medical
Ypsomed
MedNovo
EOFlow
CeQur Simplicity
Medtrum
PharmaSens
ViCentra
Key Questions Addressed in this Report
What is the 10-year outlook for the global Diabetes Drug Delivery Pump market?
What factors are driving Diabetes Drug Delivery Pump market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Diabetes Drug Delivery Pump market opportunities vary by end market size?
How does Diabetes Drug Delivery Pump break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
120 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Diabetes Drug Delivery Pump by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Diabetes Drug Delivery Pump by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
